Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

NovaWealthMgmt Aug. 21 at 4:49 PM

$PFE continues leveraging its global pharmaceutical portfolio and research capabilities across multiple therapeutic areas. AERT reaffirmed FY2027 revenue guidance of $80 million–$84 million and adjusted EBITDA guidance of $10 million–$12 million.

0 · Reply

reyofhope Aug. 21 at 4:40 PM

$PFE screw it I'm holding let's see what happens.

0 · Reply

Lord_Burglekutt Aug. 21 at 3:59 PM

$CIFR Anybody else just sell off a bunch of shit stocks and loaded heavy on this dip? 💰 $AMD $CELH $PFE $BTC.X It will rip.

0 · Reply

MJStock Aug. 21 at 3:44 PM

$BIIB $SNY $PFE ✍️ the deal for $TGTX already.

0 · Reply

Micheal_Pothead Aug. 21 at 3:01 PM

$PFE double topping it here would be a dirty move

2 · Reply

Fliptax Aug. 21 at 2:55 PM

$PFE long term https://www.businesswire.com/news/home/20260804345420/en/Pfizer-Reports-Second-Quarter-Results-And-Raises-Midpoint-of-2026-Revenue-Guidance

0 · Reply

Fliptax Aug. 21 at 2:48 PM

$PFE deserves to be much higher with the revenue that it brings in

1 · Reply

MrPeanutEsquire Aug. 21 at 2:46 PM

$PFE Still underperforming all our peers but at least were going in the same direction as everyone else this time! That a big win around here

0 · Reply

NorthOfSouth Aug. 21 at 2:45 PM

$PFE locked in some gains here from 24.35...sure to go up now...your welcome

1 · Reply

Diehard777 Aug. 21 at 2:38 PM

$PFE $SPY $MRNA Albert Bourla purchased 38,000 shares of company stock of $PFE on August 12, 2026, at an average price of $26.34 per share, totaling just over $1 million. Transaction DetailsDate: August 12, 2026Shares Purchased: 38,000Price Per Share: $26.34 Something is cooking for $PFE ☺️✅

0 · Reply

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 5 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 6 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 6 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 7 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 7 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 7 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 7 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

2026-08-07T11:40:49.000Z - 14 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 15 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

Aug 4, 2026, 10:00 AM EDT - 17 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 17 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 17 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 17 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 17 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 17 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 17 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 17 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 17 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 22 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 22 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 22 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 4 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 4 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 4 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 5 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 6 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 7 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 3 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 3 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 3 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 3 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 3 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

NovaWealthMgmt Aug. 21 at 4:49 PM

0 · Reply

reyofhope Aug. 21 at 4:40 PM

$PFE screw it I'm holding let's see what happens.

0 · Reply

Lord_Burglekutt Aug. 21 at 3:59 PM

$CIFR Anybody else just sell off a bunch of shit stocks and loaded heavy on this dip? 💰 $AMD $CELH $PFE $BTC.X It will rip.

0 · Reply

MJStock Aug. 21 at 3:44 PM

$BIIB $SNY $PFE ✍️ the deal for $TGTX already.

0 · Reply

Micheal_Pothead Aug. 21 at 3:01 PM

$PFE double topping it here would be a dirty move

2 · Reply

Fliptax Aug. 21 at 2:55 PM

$PFE long term https://www.businesswire.com/news/home/20260804345420/en/Pfizer-Reports-Second-Quarter-Results-And-Raises-Midpoint-of-2026-Revenue-Guidance

0 · Reply

Fliptax Aug. 21 at 2:48 PM

$PFE deserves to be much higher with the revenue that it brings in

1 · Reply

MrPeanutEsquire Aug. 21 at 2:46 PM

$PFE Still underperforming all our peers but at least were going in the same direction as everyone else this time! That a big win around here

0 · Reply

NorthOfSouth Aug. 21 at 2:45 PM

$PFE locked in some gains here from 24.35...sure to go up now...your welcome

1 · Reply

Diehard777 Aug. 21 at 2:38 PM

0 · Reply

Fliptax Aug. 21 at 2:35 PM

$PFE .

0 · Reply

Micheal_Pothead Aug. 21 at 2:27 PM

$PFE my 28 dollar calls

1 · Reply

PFElinepfrenzy1990 Aug. 21 at 2:08 PM

$PFE

0 · Reply

NorthOfSouth Aug. 21 at 1:51 PM

$PFE mrna dragging us up with it

0 · Reply

jackofalltrade Aug. 21 at 1:42 PM

$PFE For someone who understands options, how do all those in the money call options get paid out?

1 · Reply

ResearchTrends09 Aug. 21 at 1:20 PM

$PFE

1 · Reply

TopTierNewswire Aug. 21 at 12:19 PM

$UBER, $TSM, $PFE Top 3 long candidates identified by the Top Tier Newswire AI model!

1 · Reply

ItsCarRamRod Aug. 21 at 11:48 AM

$PFE gap fill back to $27.25 to give back all the gains from the MRNA data. Never doubted this would give back all those gains since it did not deserve them.

1 · Reply

JBS_84 Aug. 21 at 2:25 AM

$PFE I'm not a bear here first off. But I just want to express my frustration with the stock market in general When this was in the 23's a very short time ago nothing but negative articles etc Now it's flirting with 52week high and nothing but positive articles. Market is a scam against retail traders. Just something to keep a lookout for. Articles are bullshit. If you promise yourself that you would get out when you were green again on this thing, do it!

2 · Reply

Outcomes Aug. 20 at 11:52 PM

$IBRX $PFE $MRNA …mRNA BAD. https://x.com/victorsvoice2/status/2090215950343651604?s=46 Read the heartbreaking 💔 responses. And we are to believe mRNA flu vax and cancer vax are ‘safe & effective’ No thx.

1 · Reply

USAEquityResearch Aug. 20 at 11:05 PM

$PFE 📊 USAEquityResearch ▼ 27.79 (-1.59%) Trend: Bullish 📈 RSI (14): 76.8 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: 28.24 | Support: 24.54 20-MA: 26.12 | 50-MA: 25.06 💼 Fundamentals Mkt Cap: $158.39B P/E (TTM): 36.6 | Fwd P/E: 9.6 FCF: $12.49B (2.19/sh) Total Debt: $63.48B D/E: 74.25 📉 Options (exp 2026-08-28) ATM IV: 23.2% | Skew: +4.3% (put-heavy) P/C Ratio: 0.34 🐂 Bullish lean Max Pain: 26.00 Call wall: 28.00 | Put wall: 27.50 Educational content only. Not financial advice.

0 · Reply

PredictionFLO1 Aug. 20 at 8:43 PM

$PFE again. $1.2M of flagged flow through the Oct 16 $28 calls today, not shy. This is a big pharma balance sheet. Just noting it.

0 · Reply

Market Cap	160.96B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.93
Forward PE	9.15
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	15,576,478
Avg Vol	44,490,941
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	71%
Beta	0.34
Analysts	Sell
Price Target	$28.60